According to the latest equity disclosure data from the Stock Exchange of Hong Kong, on June 21st, 2024, WuXi Biologics (02269.HK) received non-executive director and chairperson Li Ge's shareholding of 1 million shares at an average price of HKD 11.6367 per share, involving approximately HKD 11.6367 million.
After the shareholding, Li Ge's latest shareholding increased from 14.22% to 14.24%, with a total shareholding of 591,457,633 shares.